Rossari Biotech Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: ₹623.00 High: ₹638.00
on August 14, 2025

52 Week Range

Low: ₹569.00 High: ₹972.70
on March 3, 2025
on September 23, 2024

All-Time High: ₹1,619.00 on October 11, 2021

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR35.3B
EPS i 24.37
P/E Ratio (TTM) i 26.15
Forward P/E i 19.00
P/B Ratio i 2.98
PEG Ratio i 19.00
Div. Yield i 6.54%
ROE i 11.50%
Beta i 0.271
Debt to Equity i 18.39

Financial Highlights

Profitability

Gross Margin i 31.70%
Operating Margin i 9.22%
Profit Margin i 6.33%

Returns and Earnings

Return on Assets (TTM) i 7.19%
Return on Equity (TTM) i 11.50%
EBITDA i INR2.7B
Net Income (TTM) i INR1.4B

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i INR385.52
Quarterly Revenue Growth (YoY) i 11.00%
Quarterly Earnings Growth (YoY) i -3.70%

Dividend Information

Last 12-Month Dividend i ₹43.78
Current Dividend Yield i 6.54%
3-Year Average Dividend Yield i 1.66%
3-Year Average Annual Dividend i ₹14.93
3-Year Total Dividends i ₹44.78
Ex-Dividend Date i June 20, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Rossari Biotech ROSSARI 35.28B Small-cap-8.85%-8.83%-7.29%-5.32%-19.77%-30.03%-31.89%-19.93%
Asian Paints ASIANPAINT 2.38T Large-cap1.70%3.19%5.17%11.22%7.53%-18.69%-28.84%26.57%
Pidilite Industries PIDILITIND 1.56T Large-cap3.47%4.62%0.81%9.65%8.30%1.29%13.82%112.62%
Balaji Amines BALAMINES 49.92B Small-cap1.24%-12.46%18.38%-2.03%-14.55%-29.13%-57.00%78.37%
Camlin Fine Sciences CAMLINFINE 40.38B Small-cap-20.63%-26.84%24.22%53.43%54.32%108.40%78.41%139.44%
Grauer & Weil GRAUWEIL 43.44B Small-cap1.00%-8.63%14.99%3.51%-8.98%1.69%42.58%122.46%

Ownership & Short Interest

Insider Ownership i 68.17%
Institutional Ownership i 20.35%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 57K
Average 90-Day Volume i 124K

Rossari Biotech Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Rossari Biotech would have performed over time.

INR
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Rossari Biotech reached a high of ₹972.70 (on September 23, 2024) and a low of ₹569.00 (on March 3, 2025).
Curious about Rossari Biotech's size and valuation? Its market capitalization stands at 35.28B. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.15, and the forward P/E (looking ahead) is 19.00.
Yes, Rossari Biotech is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 6.54%, and the company has paid an average of ₹14.93 per share annually over the past 3 years.

When looking at Rossari Biotech, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Asian Paints
ASIANPAINT
2.38TBasic MaterialsSpecialty Chemicals-18.69%-28.84%
Pidilite Industries
PIDILITIND
1.56TBasic MaterialsSpecialty Chemicals1.29%13.82%
Balaji Amines
BALAMINES
49.92BBasic MaterialsSpecialty Chemicals-29.13%-57.00%
Camlin Fine Sciences
CAMLINFINE
40.38BBasic MaterialsSpecialty Chemicals108.40%78.41%
Grauer & Weil
GRAUWEIL
43.44BBasic MaterialsSpecialty Chemicals1.69%42.58%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Rossari Biotech's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.50%, the Debt to Equity ratio from the most recent quarter is 18.39, and its Gross Profit Margin stands at 31.70%.
Looking at Rossari Biotech's growth, its revenue over the trailing twelve months (TTM) was INR21B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.00%, and quarterly earnings saw a YoY growth of -3.70%.
Wondering who owns Rossari Biotech stock? Company insiders (like executives and directors) hold about 68.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 20.35%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.